作者:
Soria, J. C. [1]
;
Gan, H. K. [2]
;
Blagden, S. P. [3]
;
Plummer, R. [4]
;
Arkenau, H. T. [5]
;
Ranson, M. [6]
;
Evans, T. R. J. [7]
;
Zalcman, G. [8]
;
Bahleda, R. [9]
;
Hollebecque, A. [10]
;
Lemech, C. ;
Dean, E. ;
Brown, J. ;
Gibson, D. ;
Peddareddigari, V. ;
Murray, S. ;
Nebot, N. ;
Mazumdar, J. ;
Swartz, L. ;
Auger, K. R. ;
Fleming, R. A. ;
Singh, R. ;
Millward, M.
作者单位:
Univ Paris Sud, Drug Dev Dept, Gustave Roussy Canc Campus, Paris, France
[1]
Sarah Cannon Res Inst, London, England
[2]
Univ Manchester, Christie Hosp, Manchester, Lancs, England
[3]
Austin Hlth, Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia
[4]
Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[5]
Imperial Coll, Hammersmith Hosp, London, England
[6]
Caen Univ Hosp, Early Phases Clin Trials Unit, Caen, France
[7]
GlaxoSmithKline, Res Triangle Pk, NC USA
[8]
Northern Ctr Canc Care, Newcastle, NSW, Australia
[9]
Univ Western Australia, Sir Charles Gairdner Hosp, Sch Med & Pharmacol, Perth, WA, Australia
[10]
发布时间
2017-05-26